Pfizer Advances COVID-19 Vaccine Trial for Children 11 and Younger

With vaccines expected to be available to this age group as soon as this fall

A 15-year-old receives the Pfizer-BioNTech vaccine against the CCP virus in Bloomfield Hills, Mich., on May 13, 2021. Jeff Kowalsky/AFP via Getty Images

Pharmaceutical company Pfizer said it’s moving forward with trials of its COVID-19 vaccine for children between the ages of five and 11, and expects to make the vaccine available in the fall.

If studies show a good immune response and safety, it will then launch the vaccine for children aged six months to five.